Similar articles for PMID: 24122947

Year	Number of Results
2000	1
2001	1
2002	1
2003	1
2004	1
2006	1
2007	3
2008	3
2009	2
2010	5
2011	2
2012	8
2013	14
2014	24
2015	16
2016	7
2017	6
2018	7
2019	6
2020	9
2021	7
2022	8
2023	1
2024	0

1

Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge.

Sharifi M, Bay C, Schwartz F, Skrocki L. Sharifi M, et al. Clin Cardiol. 2014 Feb;37(2):78-82. doi: 10.1002/clc.22216. Epub 2013 Oct 7. Clin Cardiol. 2014. PMID: 24122947 Free PMC article.

2

Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.

Sharifi M, Vajo Z, Freeman W, Bay C, Sharifi M, Schwartz F. Sharifi M, et al. Lung. 2015 Jun;193(3):369-74. doi: 10.1007/s00408-015-9702-1. Epub 2015 Mar 7. Lung. 2015. PMID: 25749665

3

Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.

Graif A, Kimbiris G, Grilli CJ, Agriantonis DJ, Putnam SG, Leung DA. Graif A, et al. J Vasc Interv Radiol. 2020 Apr;31(4):537-543. doi: 10.1016/j.jvir.2019.12.003. Epub 2020 Jan 17. J Vasc Interv Radiol. 2020. PMID: 31959518

4

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.

Beyer-Westendorf J, Lützner J, Donath L, Tittl L, Knoth H, Radke OC, Kuhlisch E, Stange T, Hartmann A, Günther KP, Weiss N, Werth S. Beyer-Westendorf J, et al. Thromb Haemost. 2013 Jan;109(1):154-63. doi: 10.1160/TH12-07-0510. Epub 2012 Nov 29. Thromb Haemost. 2013. PMID: 23197272

5

Rivaroxaban: an oral factor Xa inhibitor.

Thomas TF, Ganetsky V, Spinler SA. Thomas TF, et al. Clin Ther. 2013 Jan;35(1):4-27. doi: 10.1016/j.clinthera.2012.12.005. Clin Ther. 2013. PMID: 23328267 Review.

6

Rivaroxaban plus Percutaneous catheter-directed treatment for a patient with massive pulmonary embolism and colporrhagia.

Wang W. Wang W. Am J Emerg Med. 2018 Aug;36(8):1522.e5-1522.e7. doi: 10.1016/j.ajem.2018.04.035. Epub 2018 Apr 19. Am J Emerg Med. 2018. PMID: 29709396

7

Use of rivaroxaban could trim hospital spending in treating pulmonary embolism.

Caffrey MK. Caffrey MK. Am J Manag Care. 2014 May;20(8 Spec No.):E12. Am J Manag Care. 2014. PMID: 25617931 Free article. No abstract available.

8

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.

9

Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.

Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW. Fermann GJ, et al. Acad Emerg Med. 2015 Mar;22(3):299-307. doi: 10.1111/acem.12615. Epub 2015 Feb 25. Acad Emerg Med. 2015. PMID: 25716463 Free PMC article. Clinical Trial.

10

The use of rivaroxaban for short- and long-term treatment of venous thromboembolism.

Cohen AT, Dobromirski M. Cohen AT, et al. Thromb Haemost. 2012 Jun;107(6):1035-43. doi: 10.1160/TH11-12-0859. Epub 2012 Feb 28. Thromb Haemost. 2012. PMID: 22371186 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year